About: Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.57 (+2.61%)
ALZN NASDAQ Alzamend Neuro Inc
Alzamend Neuro Inc share price
ALZN price activity
Last Price
$1.570
Change (24hr)
0.04 USD (2.61%)
Volume
11.24K
Volume (4w avg)
-
Open
$1.60
Day Range
$1.52 - $1.62
Previous Close
$1.53
Last Trade
05 Nov, 2:37 pm GMT+0
Delayed
05 Nov, 2:37 pm GMT+0
ALZN price performance
Delayed
05 Nov, 2:37 pm GMT+0
ALZN details
ALZN Market Signals